INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 28 February 2015
Net Assets |
£238m |
Net Assets per share |
570p |
Share price |
495p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
88 |
Top Ten Holdings
Company Name |
% NAV |
Biogen-Idec |
8.4 |
Celgene |
8.0 |
Gilead |
6.2 |
Amgen |
4.7 |
Chimerix |
4.7 |
Vertex |
4.7 |
Pharmacyclics |
3.6 |
Regeneron |
3.6 |
Alexion |
3.1 |
Cempra |
3.0 |
|
----------- |
Total |
50.0 |
Portfolio Profitability |
% NAV |
Profitable |
51 |
Turning Profitable 2015 |
6 |
Unprofitable |
43 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
90 |
Europe & UK |
10 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
93 |
Unquoted |
7 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 MARCH 2015